≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Respiratory and cardiovascular disorders specific to the perinatal period

EFO MESH Endpoint Browser PheWeb

P16_RESPI_CARDIOV_DISORD_SPECIFIC_PERINA_PERIOD

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — P20-P29
  • Cause of death: ICD-10 — P20-P29

2 out of 7 registries used, show all original rules.

939

4. Check minimum number of events

None

939

5. Include endpoints

939

6. Filter based on genotype QC (FinnGen only)

939

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
P
Name in latin
Perturbationes respiratoriae et cardiovasculares temporis perinatalis specificae

Similar endpoints

↥

List of similar endpoints to Respiratory and cardiovascular disorders specific to the perinatal period based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 72975 31693 41278
Only index persons 31986 13548 18438
Unadjusted period prevalence (%)
Whole population 1.05 0.91 1.15
Only index persons 0.62 0.50 0.70
Median age at first event (years)
Whole population 0.00 0.00 0.00
Only index persons 0.00 0.00 0.00

-FinnGen-

Key figures

All Female Male
Number of individuals 939 505 434
Unadjusted period prevalence (%) 0.18 0.17 0.19
Median age at first event (years) 0.00 0.00 0.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
757
Matched controls
6856
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P22.1
ICD-10 Finland
Transient tachypnoea of newborn
+∞
211.8
200
*
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
16.2
132.7
233
183
P07.3
ICD-10 Finland
Other preterm infants
16.0
121.0
212
162
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
+∞
113.5
110
*
P22.9
ICD-10 Finland
Respiratory distress of newborn, unspecified
+∞
103.9
101
*
P21.1
ICD-10 Finland
Mild and moderate birth asphyxia
+∞
98.7
96
*
WX722
NOMESCO Finland
PEEP
21.2
63.2
97
47
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
576.0
58.3
59
*
P21.0
ICD-10 Finland
Severe birth asphyxia
+∞
55.9
55
*
P07.2
ICD-10 Finland
Extreme immaturity
236.5
46.7
49
*
P29.30
ICD-10 Finland
Delayed closure of the ductus arteriosus
+∞
42.5
42
*
P22.8
ICD-10 Finland
Other respiratory distress of newborn
195.7
38.6
41
*
P59.0
ICD-10 Finland
Neonatal jaundice associated with preterm delivery
11.9
32.1
61
50
P25.1
ICD-10 Finland
Pneumothorax originating in the perinatal period
+∞
30.3
30
*
P29.31
ICD-10 Finland
Persistent fetal circulation
+∞
27.2
27
*
P29.9
ICD-10 Finland
Cardiovascular disorder originating in the perinatal period, unspecified
+∞
27.2
27
*
WX882
NOMESCO Finland
High dependency care
3.3
26.4
150
474
P70.4
ICD-10 Finland
Other neonatal hypoglycaemia
6.7
25.9
69
101
602
Kela drug reimbursment
Children's severe malnutrition
5.0
25.8
88
175
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
4.6
25.2
93
201
H35.1
ICD-10 Finland
Retinopathy of prematurity
243.6
24.8
26
*
P24.0
ICD-10 Finland
Neonatal aspiration of meconium
+∞
23.2
23
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.7
22.6
179
699
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
20.4
138
486
P36.90
ICD-10 Finland
Suspected bacterial sepsis of newborn
8.2
19.3
44
51
P28.4
ICD-10 Finland
Other apnoea of newborn
+∞
19.1
19
*
P07.10
ICD-10 Finland
Other low birth weight 1000-1499 g
32.0
18.1
24
7
J45.1
ICD-10 Finland
Nonallergic asthma
2.8
17.9
128
465
P07.11
ICD-10 Finland
Other low birth weight 1500-1999 g
10.7
17.9
35
31
R4110
NOMESCO Finland
Physiotherapy
2.2
16.8
222
1103
F82
ICD-10 Finland
Specific developmental disorder of motor function
4.0
16.4
69
169
P21.9
ICD-10 Finland
Birth asphyxia, unspecified
+∞
16.1
16
*
P70.0
ICD-10 Finland
Syndrome of infant of mother with gestational diabetes
7.9
16.1
37
44
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
15.9
143
588
P07.02
ICD-10 Finland
Extremely low birth weight 750-999 g
157.1
15.9
17
*
Z3231
NOMESCO Finland
Registered nurse
1.9
15.8
333
1987
P01.5
ICD-10 Finland
Fetus and newborn affected by multiple pregnancy
11.9
15.2
28
22
P07.01
ICD-10 Finland
Extremely low birth weight 500-749 g
+∞
15.1
15
*
WX730
NOMESCO Finland
Conventional respirator
8.8
14.9
32
34
P07.1
ICD-10 Finland
Other low birth weight
24.4
14.9
21
8
Z3226
NOMESCO Finland
Physiotherapist
2.0
14.5
229
1213
P39.9
ICD-10 Finland
Infection specific to the perinatal period, unspecified
6.6
14.3
37
53
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
8.8
14.0
30
32
FDE00
NOMESCO Finland
Closure of patent ductus arteriosus
138.2
13.9
15
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.7
13.7
97
348
Z2221
NOMESCO Finland
Medical doctor
2.0
13.5
223
1200
P70.1
ICD-10 Finland
Syndrome of infant of a diabetic mother
9.7
13.3
27
26
P20.1
ICD-10 Finland
Intrauterine hypoxia first noted during labour and delivery
+∞
13.1
13
*
P05.1
ICD-10 Finland
Small for gestational age
7.1
12.7
31
41
XG413
NOMESCO Finland
Spirometry with oscillometry
4.2
12.6
48
108
Z2446
NOMESCO Finland
Social worker
2.0
12.5
177
891
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
14.7
11.5
19
12
P25.2
ICD-10 Finland
Pneumomediastinum originating in the perinatal period
+∞
11.0
11
*
P01.10
ICD-10 Finland
Fetus and newborn affected by premature rupture of membranes 1-7 days before delivery
7.7
10.5
24
29
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.8
10.4
69
239
R03BA05
ATC
fluticasone; inhalant
1.8
10.4
207
1174
P00.0
ICD-10 Finland
Fetus and newborn affected by maternal hypertensive disorders
7.4
10.3
24
30
ZX114
NOMESCO Finland
Intramuscular
5.0
10.1
32
60
P29.1
ICD-10 Finland
Neonatal cardiac dysrhythmia
+∞
10.0
10
*
P23.9
ICD-10 Finland
Congenital pneumonia, unspecified
+∞
10.0
10
*
P07.12
ICD-10 Finland
Other low birth weight 2000-2499 g
5.1
10.0
31
57
JAB00
NOMESCO Finland
Division and ligature of inguinal hernia sac
4.0
9.9
39
91
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.4
9.8
85
340
J21.90
ICD-10 Finland
Acute obstructive bronchitis in children
2.6
9.7
71
259
R03AC02
ATC
salbutamol; inhalant
1.6
9.7
406
2838
P05.0
ICD-10 Finland
Light for gestational age
8.1
9.6
21
24
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
9.5
169
915
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
9.5
283
1803
R03BA02
ATC
budesonide; inhalant
2.0
9.4
137
693
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
9.4
228
1369
XA800
NOMESCO Finland
Neuropsychological investigation
2.2
9.2
96
423
R62.0
ICD-10 Finland
Delayed milestone
2.4
9.0
78
311
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
8.8
134
684
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.8
8.7
166
918
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
8.7
167
929
P02.1
ICD-10 Finland
Fetus and newborn affected by other forms of placental separation and haemorrhage
33.6
8.6
11
*
P29.8
ICD-10 Finland
Other cardiovascular disorders originating in the perinatal period
+∞
8.0
8
*
F80.1
ICD-10 Finland
Expressive language disorder
2.9
8.0
47
152
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
7.9
127
660
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.1
7.8
93
431
RT150
NOMESCO Finland
NA
3.6
7.7
34
89
M03BX01
ATC
baclofen; systemic
10.7
7.6
14
12
UGC02
NOMESCO Finland
Rigid bronchoscopy
4.5
7.5
25
51
WX704
NOMESCO Finland
Intubation
2.7
7.4
48
165
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
7.3
239
1538
RK312
NOMESCO Finland
NA
6.0
7.3
19
29
H50.30
ICD-10 Finland
Intermittent esotropy
3.3
7.2
34
95
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.0
7.2
41
130
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
7.1
103
516
Q25.0
ICD-10 Finland
Patent ductus arteriosus
3.6
7.1
31
81
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
7.0
66
277
P24.1
ICD-10 Finland
Neonatal aspiration of amniotic fluid and mucus
+∞
7.0
7
*
P07.0
ICD-10 Finland
Extremely low birth weight
+∞
7.0
7
*
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.9
6.9
100
502
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.7
6.8
139
780
WW805
NOMESCO Finland
Transfer from treating institution to lower-Level care, accompanied by paramedic/nurse
9.9
6.8
13
12
P03.4
ICD-10 Finland
Fetus and newborn affected by caesarean delivery
9.9
6.8
13
12
7AA02
NOMESCO Finland
NA
27.4
6.8
9
*
P52.2
ICD-10 Finland
Intraventricular (nontraumatic) haemorrhage, grade 3, and grade 4 of fetus and newborn
27.4
6.8
9
*
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
2.9
6.8
39
124
P52.0
ICD-10 Finland
Intraventricular (nontraumatic) haemorrhage, grade 1, of fetus and newborn
18.3
6.8
10
5
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
6.6
128
708
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.0
6.6
80
374
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
3.2
6.6
32
92
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
6.5
200
1258
6BB16
NOMESCO Finland
NA
12.6
6.5
11
8
RK520
NOMESCO Finland
NA
6.9
6.4
15
20
J21.9
ICD-10 Finland
Acute bronchiolitis, unspecified
2.0
6.4
79
375
WX732
NOMESCO Finland
High frequency respirator
20.6
6.3
9
*
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.5
6.2
266
1806
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
2.3
6.2
55
224
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
1.7
6.2
151
892
ZX108
NOMESCO Finland
Inhalation
4.0
6.2
23
53
P36.3
ICD-10 Finland
Sepsis of newborn due to other and unspecified staphylococci
63.9
6.2
7
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
2.8
6.1
39
132
P08.1
ICD-10 Finland
Other heavy for gestational age infants
9.2
6.1
12
12
P24.3
ICD-10 Finland
Neonatal aspiration of milk and regurgitated food
+∞
6.0
6
*

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022313) Gas panel - Capillary blood
223
1359
1.61
8.16
15.5
9.5
—
—
—
0
0
(3022670) pH of Venous cord blood
22
50
4.00
7.66
1.0
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
244
1549
1.55
7.41
16.9
9.4
mmol/l
1.1
0.8
0.76
180
1117
(3009343) pH of Capillary blood
244
1553
1.55
7.31
17.0
9.5
ph
7.4
7.4
—
9
56
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
244
1553
1.55
7.31
17.0
9.5
kpa
5.1
5.0
2.04
234
1506
(3005322) IgE [Units/volume] in Serum or Plasma
143
823
1.65
6.47
1.5
1.5
u/ml
207.5
358.4
1.36
136
778
(3028626) Oxygen [Partial pressure] in Capillary blood
224
1440
1.51
6.29
16.4
9.3
kpa
9.5
9.8
1.95
214
1396
(3003458) Phosphate [Moles/volume] in Serum or Plasma
221
1436
1.49
5.85
14.4
11.4
mmol/l
1.4
1.3
1.31
212
1376
(3000991) Gas panel - Venous blood
216
1417
1.47
5.41
12.5
11.8
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
12
22
4.92
5.39
1.2
1.5
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
24
74
2.94
5.36
8.5
10.4
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
21
60
3.17
5.32
9.7
7.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
432
3216
1.38
5.24
10.7
7.9
mmol/l
5.8
6.0
0.69
413
3018
(40758558) Short blood count panel - Blood
321
2283
1.39
5.11
8.5
9.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
219
1456
1.45
5.09
8.9
9.8
mmol/l
23.7
23.6
0.05
209
1427
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
393
2901
1.37
4.93
20.6
13.6
mmol/l
1.2
1.2
0.31
379
2785
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
197
1294
1.46
4.86
3.2
3.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
223
1509
1.42
4.67
3.3
3.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
229
1563
1.41
4.56
12.4
10.1
mmol/l
1.3
1.1
0.37
182
1243
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
401
3013
1.33
4.30
20.2
12.3
mmol/l
1.2
1.2
0.12
378
2802
(42870560) Thyrotropin [Units/volume] in Cord blood
68
360
1.74
4.21
1.0
1.0
mu/l
11.8
8.2
2.11
61
312
(3020393) Adenovirus Ag [Presence] in Stool
36
154
2.13
4.16
1.7
2.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
400
3022
1.32
4.06
9.2
10.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
21
71
2.68
4.03
7.0
6.8
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
21
71
2.68
4.03
6.4
6.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
188
1266
1.41
4.00
4.5
3.8
e6/l
2.4
3.0
0.47
112
715
(3024354) Oxygen [Partial pressure] in Venous blood
218
1507
1.38
3.97
11.6
9.9
kpa
5.3
5.1
0.67
213
1476
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
27
105
2.33
3.91
1.0
1.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
504
3954
1.31
3.79
9.2
9.5
%
37.3
35.7
2.06
489
3785
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
43
205
1.91
3.74
2.0
2.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
495
3880
1.30
3.72
8.9
9.4
%
47.3
48.8
1.67
482
3725
(3002582) Erythrocytes [#/volume] in Urine
285
2073
1.33
3.70
5.6
4.5
e6/l
227.8
33.8
0.50
219
1560
(3034988) Calcium [Moles/volume] in Capillary blood
17
54
2.84
3.66
15.7
10.9
mmol/l
1.2
1.2
0.29
17
49
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
183
1245
1.39
3.65
4.2
3.7
e6/l
0.7
0.9
0.83
107
692
(3019198) Lymphocytes [#/volume] in Blood
508
4004
1.30
3.62
9.4
9.4
e9/l
2.6
2.4
1.53
448
3442
(40768446) Kidney Pathology biopsy report
22
81
2.46
3.60
3.0
2.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
297
2181
1.32
3.59
6.2
4.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
271
1965
1.33
3.58
5.1
4.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
481
3770
1.29
3.55
9.3
9.7
%
3.1
3.3
0.92
467
3607
(3019069) Monocytes/100 leukocytes in Blood
484
3801
1.29
3.50
9.6
9.8
%
8.4
8.3
0.75
467
3634
(3022096) Basophils/100 leukocytes in Blood
470
3678
1.29
3.49
9.2
9.8
%
0.6
0.6
0.51
456
3523
(3030467) Casts [#/volume] in Urine by Automated count
268
1947
1.32
3.48
5.3
4.4
e6/l
0.2
0.2
0.24
202
1439
(3036489) Thrombin time
83
489
1.57
3.44
4.5
7.9
s
23.2
23.3
0.03
75
478
(3015377) Calcium [Moles/volume] in Serum or Plasma
197
1374
1.36
3.35
3.6
2.9
mmol/l
2.4
2.4
0.13
185
1256
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
100
618
1.50
3.34
2.5
2.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
153
1025
1.40
3.33
3.9
4.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
524
4172
1.28
3.33
11.0
11.2
e9/l
3.4
3.4
0.11
452
3479
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
160
1844
0.73
3.32
2.5
2.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
505
4003
1.28
3.32
10.2
10.3
e9/l
0.2
0.2
0.60
446
3408
(4306422)
21
79
2.40
3.30
1.0
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
139
919
1.41
3.27
15.0
13.5
mmol/l
0.8
0.8
1.92
133
888
(3037121) Protein [Mass/volume] in Urine
69
394
1.61
3.26
9.5
8.2
g/l
0.7
0.4
0.76
55
318
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
172
1952
0.74
3.22
2.6
2.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
491
3894
1.27
3.14
9.6
9.5
e9/l
0.0
0.0
0.21
424
3245
(3021589) Normoblasts [#/volume] in Blood
464
3655
1.27
3.14
10.7
11.2
e9/l
0.0
0.0
0.80
373
2809
(40757494) Bilirubin.total [Moles/volume] in Blood
16
54
2.67
3.12
7.9
3.9
umol/l
99.7
167.1
—
9
29
(3001604) Monocytes [#/volume] in Blood
490
3896
1.26
3.02
9.6
9.5
e9/l
0.6
0.6
2.53
423
3245
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
123
809
1.41
2.98
2.5
2.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
51
278
1.67
2.91
1.8
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
51
278
1.67
2.91
1.8
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
48
258
1.70
2.89
2.6
2.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
48
259
1.69
2.85
2.6
2.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
270
2010
1.28
2.84
7.6
8.9
umol/l
34.2
22.3
2.78
252
1827
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
16
57
2.53
2.83
1.4
1.6
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
9
20
4.04
2.79
1.0
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
48
261
1.68
2.78
2.8
2.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
98
627
1.44
2.77
2.8
2.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
125
836
1.39
2.76
2.1
1.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
317
2423
1.26
2.65
4.8
3.6
nmol/l
69.6
67.8
0.56
301
2305
(3027945) Reticulocytes/100 erythrocytes in Blood
136
929
1.36
2.64
6.0
7.4
%
1.5
1.4
1.04
130
881
(3023419) Bacteria identified in Sputum by Culture
8
17
4.22
2.63
13.0
16.5
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
32
157
1.85
2.62
3.5
4.6
umol/l
25.9
23.8
0.51
32
157
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
13
4.83
2.61
7.1
8.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
11
34
2.91
2.51
1.1
1.4
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
6
10
5.38
2.47
7.0
3.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
34
174
1.77
2.45
1.4
1.8
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
101
665
1.40
2.45
14.8
16.0
mmol/l
1.2
1.3
0.93
94
597
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
41
222
1.68
2.44
14.7
13.2
u/ml
111.3
286.0
—
7
30
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
14
51
2.47
2.39
1.6
1.6
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
49
281
1.59
2.34
1.0
1.0
kpa
7.3
7.3
0.04
39
238
(3006598) pH of Arterial cord blood
49
281
1.59
2.34
1.0
1.0
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
49
281
1.59
2.34
1.0
1.0
mmol/l
-3.3
-2.1
0.33
11
62
(3018095) Leukocytes [#/volume] in Urine
312
2410
1.23
2.32
6.9
5.4
e6/l
53.7
54.9
0.02
225
1622
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
51
296
1.57
2.32
2.0
1.7
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
6
11
4.89
2.32
2.3
3.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
53
314
1.54
2.22
1.8
1.8
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
48
278
1.57
2.21
1.0
1.0
kpa
3.6
3.3
0.33
38
236
(3002179) Metamyelocytes/100 leukocytes in Blood
58
351
1.51
2.20
6.5
5.1
%
0.4
0.3
0.15
18
81
(3023103) Potassium [Moles/volume] in Serum or Plasma
664
5559
1.24
2.18
19.2
12.8
mmol/l
4.0
3.9
6.77
652
5371
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
44
251
1.59
2.17
15.1
10.6
iu/ml
647.7
431.1
—
9
35
(3024891) Influenza virus A+B Ag [Presence] in Specimen
63
390
1.47
2.15
1.7
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
91
605
1.38
2.11
2.0
2.0
—
—
—
0
0
(44790047)
38
211
1.63
2.09
2.8
2.2
—
—
—
0
0
(44790049)
38
211
1.63
2.09
2.8
2.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
31
163
1.72
2.08
7.2
7.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
61
379
1.47
2.06
7.1
5.9
%
0.6
0.5
0.24
25
118
(44790048)
38
212
1.62
2.05
2.8
2.2
—
—
—
0
0
(44806118)
38
212
1.62
2.05
2.8
2.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
37
205
1.64
2.05
1.8
2.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
57
350
1.48
2.04
7.2
6.0
%
0.0
0.0
0.00
20
94
(3000494) Fungus identified in Specimen by Culture
81
532
1.39
2.03
2.3
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
35
192
1.65
2.02
1.9
1.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
193
1434
1.25
2.02
5.6
4.7
mmol/l
8.0
8.8
1.04
183
1365
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
22
106
1.87
1.96
1.1
1.5
u/ml
1.6
4.8
—
8
56
(3019550) Sodium [Moles/volume] in Serum or Plasma
662
5565
1.22
1.95
19.4
12.8
mmol/l
139.3
139.5
1.45
652
5405
(3004809) Band form neutrophils/100 leukocytes in Blood
19
87
1.97
1.95
2.6
5.0
%
0.5
1.0
0.86
14
69
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
106
733
1.33
1.93
4.8
8.8
umol/l
4.9
6.6
1.86
87
616
(3045788) Cell count panel - Pleural fluid
7
19
3.30
1.91
1.3
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
164
1203
1.26
1.91
5.5
4.5
inr
1.1
1.1
0.81
40
323
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
113
790
1.31
1.91
4.4
5.1
g/l
0.2
0.2
0.65
106
763
(40767503) Oxygen content in Capillary blood by calculation
25
127
1.78
1.90
4.7
3.2
%
17.8
17.7
0.04
19
83
(3000570) Elastase.pancreatic [Mass/mass] in Stool
29
154
1.70
1.90
1.2
1.3
ug/g
399.3
363.9
0.41
16
77
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
21
102
1.86
1.84
1.1
1.5
u/ml
4.6
4.3
—
9
65
(3006653) Thiamine [Moles/volume] in Blood
6
15
3.58
1.83
1.0
1.1
nmol/l
156.7
134.1
—
6
15
(3024561) Albumin [Mass/volume] in Serum or Plasma
239
1838
1.22
1.80
12.0
8.8
g/l
36.7
38.1
2.93
233
1753
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
263
2047
1.20
1.75
4.4
4.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
736
6283
1.23
1.70
10.9
7.9
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
724
6175
1.22
1.66
19.1
15.2
%
13.3
13.1
2.33
714
6060
(3020891) Body temperature
24
126
1.72
1.66
13.4
6.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
15
68
1.98
1.61
4.3
3.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
28
155
1.63
1.61
6.1
5.7
ug/l
2.4
2.1
0.19
28
155
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
28
155
1.63
1.61
1.6
1.6
nmol/l
0.2
0.2
1.09
21
128
(40768443) Skin Pathology biopsy report
7
141
0.44
1.57
1.4
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
19
95
1.80
1.55
1.2
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
18
2.99
1.55
2.2
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
76
519
1.33
1.54
2.3
2.3
iu/l
10.6
7.6
0.50
52
337
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
215
1662
1.20
1.53
3.3
3.4
mg/l
2.7
2.7
0.06
188
1509
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
76
1.89
1.52
3.2
1.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
112
0.39
1.52
1.0
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
41
518
0.69
1.51
1.3
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
15
70
1.93
1.50
1.3
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
83
1.84
1.49
16.8
8.5
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
20
103
1.75
1.49
4.9
5.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
60
398
1.37
1.47
1.3
1.5
—
—
—
0
0
(3019225) pH of Specimen
36
217
1.50
1.46
3.4
5.4
—
—
—
0
0
(4198724)
7
135
0.46
1.45
1.4
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
42
262
1.45
1.45
2.0
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
27
153
1.59
1.43
10.1
5.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
100
1096
0.79
1.41
1.9
2.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
55
363
1.37
1.40
2.6
2.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
126
934
1.24
1.37
3.7
5.2
mg/l
1.5
1.9
0.62
88
651
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
37
2.18
1.35
2.0
1.7
—
—
—
0
0
(4010399)
49
321
1.38
1.32
1.5
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
6
21
2.56
1.32
3.0
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
10
42
2.14
1.31
2.4
2.6
umol/l
23.4
18.7
—
10
42
(3021440) Promyelocytes/100 leukocytes in Blood
54
360
1.36
1.31
7.7
5.9
%
0.0
0.1
0.09
24
108
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
34
209
1.47
1.28
1.2
3.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
5
16
2.80
1.27
1.2
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
16
2.80
1.27
1.0
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
16
2.80
1.27
2.2
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
126
942
1.22
1.27
1.7
1.9
mmol/l
1.4
1.2
1.24
115
875
(3031040) Bacteria [#/volume] in Urine by Automated count
428
3541
1.15
1.27
5.1
3.9
e6/l
7.4
208.5
—
5
44
(3026782) Osmolality of Urine
174
1343
1.19
1.26
4.6
3.5
mosm/kgh2o
561.0
605.8
1.32
156
1165
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
62
1.88
1.24
1.5
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
351
2868
1.15
1.23
3.6
3.1
mmol/mol
35.3
36.2
0.95
328
2707
(44813793)
24
138
1.57
1.23
1.1
1.1
—
—
—
0
0
(4035726)
47
310
1.37
1.23
1.7
1.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
79
563
1.28
1.21
7.8
7.4
ng/l
1764.2
1102.9
0.58
71
476
(3028707) Methadone [Presence] in Urine by Screen method
34
423
0.71
1.19
1.7
2.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
80
574
1.27
1.17
15.5
12.5
mmol/l
105.0
105.7
0.59
80
567
(3003327) Ova and parasites identified in Stool by Light microscopy
60
415
1.31
1.16
1.7
1.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
156
1202
1.19
1.16
5.3
4.1
ph
7.4
7.4
1.30
27
201
(3021960) Folate [Moles/volume] in Serum or Plasma
96
705
1.24
1.16
1.5
1.4
nmol/l
22.0
19.0
1.17
82
634
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
64
1.82
1.14
3.5
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
71
1.77
1.13
1.4
1.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
18
2.49
1.13
1.4
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
45
1.99
1.12
1.4
1.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
38
247
1.39
1.10
19.1
21.8
%
0.7
0.8
1.26
38
247
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
121
1261
0.83
1.08
2.0
2.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
38
248
1.38
1.08
19.2
21.8
%
95.4
96.1
0.21
38
248
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
747
6847
0.85
1.07
4.1
3.8
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
838
7326
1.25
1.04
19.7
15.7
e9/l
7.1
6.9
1.07
803
6931
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
16
87
1.65
1.04
1.1
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
174
1369
1.17
1.02
4.8
3.6
e6/l
6.4
6.3
0.05
157
1197
(3011397) Hemoglobin [Presence] in Urine by Test strip
189
1497
1.16
1.01
4.7
3.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
162
1268
1.17
1.01
8.2
5.0
—
—
—
0
0
(3024731) MCV [Entitic volume]
836
7310
1.24
1.01
19.6
15.6
fl
85.5
85.8
1.25
826
7188
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
151
1176
1.17
1.00
1.6
1.5
pmol/l
102.0
97.0
0.61
73
634
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
737
6379
1.16
0.98
13.4
10.9
mg/l
21.6
23.4
0.86
504
4255
(3035941) MCH [Entitic mass]
836
7313
1.23
0.98
19.6
15.6
pg
28.8
28.8
0.59
826
7194
(3028300) Cannabinoids [Presence] in Urine
84
897
0.82
0.98
1.5
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
83
887
0.82
0.97
1.5
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
25
315
0.70
0.97
1.0
1.0
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
836
7314
1.23
0.97
19.7
15.6
e12/l
4.6
4.6
0.44
804
6904
(3019060) Gas panel - Arterial blood
17
96
1.59
0.97
7.2
3.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
0
29
0.00
0.95
0.0
1.6
—
43.0
—
0
23
(1001926) Buprenorphine [Presence] in Urine by Screen method
65
711
0.80
0.95
1.4
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
84
894
0.82
0.95
1.5
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
49
341
1.30
0.94
16.8
16.8
mmol/l
-0.5
-0.1
0.37
44
265
(1761868) Lipid panel - Serum or Plasma
124
956
1.18
0.94
1.9
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
78
834
0.82
0.92
1.4
1.9
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
836
7319
1.22
0.92
20.1
16.0
g/l
132.3
133.0
0.61
826
7206
(3019309) Folate [Moles/volume] in Red Blood Cells
44
303
1.31
0.92
1.4
1.6
nmol/l
1579.3
1056.9
2.36
31
239
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
19
112
1.52
0.91
1.5
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
41
280
1.32
0.90
5.9
3.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
55
609
0.79
0.90
1.5
2.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
83
878
0.83
0.89
1.5
1.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
834
7305
1.21
0.87
19.8
15.7
e9/l
275.0
272.6
0.45
801
6922
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
12
172
0.62
0.87
1.1
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
67
491
1.23
0.86
2.5
2.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
78
581
1.22
0.86
2.4
2.3
u/l
6.3
5.7
0.17
46
372
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
66
483
1.24
0.86
2.5
2.0
u/ml
207.2
166.3
0.34
28
222
(3004588) Protein electrophoresis panel - Serum or Plasma
11
57
1.73
0.85
1.6
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
57
1.73
0.85
1.2
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
40
1.79
0.84
1.3
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
40
1.79
0.84
1.3
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
738
6408
1.14
0.84
17.9
14.6
g/l
335.5
335.0
0.65
732
6333
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
6
101
0.53
0.84
1.2
1.5
u/l
5.5
10.0
—
6
91
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
395
3315
1.11
0.83
6.7
5.7
u/l
143.5
126.7
2.43
370
3126
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
36
245
1.32
0.83
8.8
5.9
mmol/l
1.2
1.2
0.71
30
222
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
98
750
1.19
0.82
2.4
2.3
ng/l
91.1
46.8
0.25
41
268
(42529406) Shigella sp [Presence] in Stool by Culture
29
191
1.37
0.82
1.2
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
18
108
1.50
0.82
1.2
1.2
—
—
—
0
0
(4268621)
13
72
1.62
0.81
2.2
2.9
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
13
72
1.62
0.81
1.6
1.7
nmol/l
20.4
19.1
—
5
23
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
5
86
0.52
0.79
11.4
7.1
mg/l
10.2
9.2
—
5
75
(3019832) Treponema pallidum Ab [Presence] in Serum
109
1111
0.86
0.78
1.8
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
19
117
1.46
0.77
3.1
2.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
178
1434
1.13
0.77
3.5
2.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
67
499
1.21
0.76
3.6
4.0
mg/l
1056.1
123.9
0.52
56
413
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
30
202
1.34
0.75
1.4
1.9
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
21
2.13
0.75
2.6
1.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
22
2.03
0.73
1.6
2.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
22
2.03
0.73
1.4
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
153
1226
1.14
0.72
5.5
3.5
estimate
0.0
0.0
0.50
48
414
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
24
286
0.74
0.71
1.3
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
51
1.58
0.71
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
36
1.74
0.71
1.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
150
1.38
0.71
1.4
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
28
189
1.33
0.70
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
211
2043
0.90
0.69
2.0
1.8
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
37
1.69
0.69
1.0
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
37
1.69
0.69
1.0
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
14
83
1.51
0.68
1.3
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
128
1.40
0.68
2.8
1.6
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
5
24
1.86
0.68
3.8
4.0
mmol/l
4.8
4.5
—
5
24
(3011985) Renin [Units/volume] in Plasma
13
76
1.53
0.67
2.0
1.9
mu/l
166.9
191.8
0.05
13
68
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
38
1.65
0.67
1.0
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
19
121
1.41
0.67
11.1
7.5
mmol/l
2.4
1.3
0.94
14
60
(3013290) Carbon dioxide [Partial pressure] in Blood
19
121
1.41
0.67
11.1
7.5
kpa
5.0
4.9
0.22
19
121
(3027315) Oxygen [Partial pressure] in Blood
19
121
1.41
0.67
8.9
7.5
kpa
9.4
9.4
0.03
19
121
(3023520) Reticulocytes [#/volume] in Blood
87
674
1.17
0.66
3.6
5.2
e9/l
61.6
64.1
0.22
60
421
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
342
2878
1.10
0.66
1.7
1.8
u/ml
1.9
3.7
1.78
60
519
(3034426) Prothrombin time (PT)
5
25
1.79
0.66
1.0
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
661
5732
1.10
0.66
9.4
9.1
u/l
28.1
25.0
0.97
645
5540
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
27
184
1.32
0.64
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
117
0.61
0.64
1.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
41
296
1.25
0.64
1.4
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
18
115
1.40
0.63
2.0
1.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
88
686
1.16
0.62
3.0
3.9
ng/l
1455.7
1427.4
0.02
54
381
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
141
1137
1.13
0.62
3.8
2.9
u/l
50.6
57.2
1.14
128
1059
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
162
1.33
0.61
12.9
24.3
u/ml
0.3
0.3
0.81
15
105
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
18
218
0.73
0.61
1.7
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
59
446
1.19
0.60
1.5
1.4
pmol/l
557.4
16625772.6
0.50
50
403
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
343
3224
0.92
0.60
7.5
6.3
ml/min/173m2
113.0
113.0
0.00
220
2006
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
20
132
1.36
0.59
1.2
1.2
—
44.8
—
0
5
(3004716) Salmonella sp identified in Stool by Organism specific culture
62
644
0.85
0.59
1.3
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
47
1.52
0.59
3.0
2.2
pg
31.8
32.1
—
8
47
(3007164) IgA [Mass/volume] in Serum or Plasma
322
2716
1.09
0.58
1.7
1.7
g/l
1.4
1.5
0.68
164
1400
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
57
1.57
0.58
1.1
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
246
0.76
0.58
1.1
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
77
0.58
0.57
1.0
1.0
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
15
95
1.42
0.56
1.4
2.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
34
245
1.25
0.56
1.1
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
48
360
1.20
0.55
1.8
1.7
e9/l
4.2
4.2
0.01
42
328
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
9
54
1.49
0.54
1.1
1.1
nmol/l
0.5
0.4
—
9
54
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
23
158
1.31
0.54
4.0
2.9
—
787.8
—
0
16
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
174
1.29
0.54
2.5
2.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
757
6631
1.11
0.53
17.5
14.7
%
39.1
39.2
0.31
686
5905
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
60
618
0.86
0.53
1.2
1.2
iu/ml
15.0
19.5
0.40
15
125
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
360
3065
1.08
0.51
3.2
2.7
mmol/l
1.1
1.1
0.32
342
2905
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
73
739
0.87
0.51
1.4
1.4
%
1.3
1.3
0.03
68
678
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
59
1.52
0.51
2.3
3.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
59
1.52
0.51
1.1
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
79
623
1.14
0.50
1.2
1.2
u/ml
7.1
6.3
0.17
61
464
(3007566) Smooth muscle Ab [Titer] in Serum
13
160
0.72
0.50
1.8
2.3
—
64.8
—
0
21
(3029634) Reagin Ab [Titer] in Serum by VDRL
24
168
1.28
0.50
1.6
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
189
1808
0.91
0.50
2.0
2.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
18
121
1.33
0.49
6.0
4.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
149
0.71
0.49
1.1
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
7
40
1.57
0.49
1.0
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
40
1.57
0.49
3.1
5.7
ug/l
259.3
222.0
—
7
40
(3026389) Candida sp identified in Specimen by Organism specific culture
7
98
0.63
0.49
1.3
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
18
209
0.76
0.48
1.1
1.1
—
—
—
0
0
(3049233) Organic acids panel - Urine
10
60
1.49
0.48
1.3
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
128
0.69
0.48
2.3
2.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
43
1.46
0.46
1.1
2.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
104
0.68
0.46
1.4
3.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
104
0.68
0.46
1.4
3.9
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
77
611
1.14
0.46
1.2
1.2
u/ml
0.9
1.0
0.06
54
430
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
538
4662
1.07
0.46
3.5
3.3
pmol/l
14.5
14.4
0.79
491
4194
(40768441) Liver Pathology biopsy report
5
76
0.58
0.46
1.4
2.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
7
44
1.42
0.45
1.9
2.9
—
29.6
—
0
13
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
39
410
0.84
0.45
1.5
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
35
261
1.20
0.44
7.7
3.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
56
570
0.87
0.44
1.2
1.2
u/ml
4.0
8.8
0.70
15
147
(3023511) Choriogonadotropin [Units/volume] in Urine
37
389
0.84
0.43
1.2
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
34
254
1.20
0.43
1.4
1.5
u/ml
9.4
10.5
0.05
23
173
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
28
1.60
0.43
1.2
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
28
1.60
0.43
1.8
2.3
nmol/l
2.2
2.8
—
5
28
(3032352) Blasts [#/volume] in Cerebral spinal fluid
8
50
1.43
0.42
6.6
6.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
85
0.63
0.42
1.3
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
25
272
0.81
0.42
2.1
2.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.41
0.0
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
14
0.00
0.41
0.0
7.5
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
13
154
0.75
0.41
1.8
2.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
5
30
1.49
0.40
1.6
2.7
ug/min
37.2
198.0
—
5
21
(3003694) ABO and Rh group [Type] in Blood
230
1943
1.07
0.40
1.6
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
16
0.00
0.40
0.0
1.9
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
16
0.00
0.40
0.0
2.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
16
0.00
0.40
0.0
2.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
366
3143
1.06
0.40
3.9
3.3
ug/l
52.5
56.6
0.20
346
2992
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
17
0.00
0.39
0.0
4.2
—
0.4
—
0
17
(3037467) Urinalysis macro (dipstick) panel - Urine
426
3678
1.06
0.39
5.4
4.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
295
2746
0.94
0.38
3.9
4.9
u/l
25.9
26.8
0.13
286
2649
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
39
299
1.17
0.38
2.2
2.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
5
32
1.40
0.38
17.8
12.3
nmol/l
570.6
744.2
—
5
32
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
13
87
1.34
0.38
1.0
1.3
—
—
—
0
0
(3000492) Spirometry study
53
417
1.14
0.38
1.5
1.4
—
—
—
0
0
(3013512) EKG study
67
664
0.89
0.37
2.6
2.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
597
5212
1.06
0.37
4.1
3.7
mu/l
2.2
2.0
2.47
561
4919
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
37
1.45
0.36
1.0
1.1
nmol/l
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
38
1.41
0.35
1.0
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
26
194
1.20
0.35
7.1
3.4
ml/min/173m2
73.5
92.6
1.04
11
49
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
82
668
1.10
0.34
1.2
1.3
u/ml
3.0
3.0
0.01
57
440
(3035350) Ketones [Presence] in Urine by Test strip
297
2547
1.06
0.34
5.1
3.4
estimate
0.0
0.0
0.00
50
412
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
41
1.31
0.33
1.0
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
52
414
1.13
0.32
4.8
3.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
215
0.83
0.32
1.5
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
39
305
1.15
0.31
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
366
3366
0.95
0.31
2.1
2.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
149
1253
1.07
0.31
1.2
1.3
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
27
205
1.18
0.31
1.3
1.2
u/ml
0.3
1.1
—
8
61
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
89
0.70
0.31
1.1
1.1
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
7
48
1.30
0.30
1.3
1.1
—
81.9
—
0
11
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
37
375
0.87
0.30
1.4
1.8
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
13
146
0.79
0.30
1.8
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
24
181
1.19
0.30
2.0
2.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
27
206
1.17
0.29
15.9
19.5
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
20
213
0.83
0.29
1.1
1.5
—
12.0
—
0
7
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
35
355
0.87
0.29
2.0
1.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
19
203
0.83
0.29
1.5
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
99
0.72
0.29
1.0
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
28
215
1.17
0.29
4.7
3.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
186
1581
1.06
0.29
4.5
5.3
u/l
37.1
33.4
0.31
181
1521
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
33
257
1.15
0.29
1.2
1.3
miu/ml
238.9
206.5
0.23
21
110
(3020682) Albumin/Creatinine [Ratio] in Urine
61
495
1.11
0.29
4.2
4.4
mg/mmol
240.7
7.8
0.57
53
410
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
57
558
0.91
0.27
1.4
1.3
iu/ml
227.9
157.6
0.39
15
172
(3029075) Extractable nuclear Ab panel - Serum
10
68
1.32
0.27
1.0
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
8
59
1.21
0.26
1.8
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
19
142
1.20
0.26
1.6
2.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
22
167
1.18
0.26
1.5
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
250
2311
0.95
0.26
2.5
2.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
85
1.26
0.25
1.9
1.3
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
35
277
1.13
0.25
1.2
1.5
u/ml
3.6
3.6
0.01
26
197
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
28
218
1.15
0.25
5.1
3.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
433
3949
0.96
0.25
4.8
4.5
mm/h
8.0
7.1
0.98
413
3661
(3012494) Peanut IgE Ab [Units/volume] in Serum
27
210
1.15
0.25
1.4
1.3
u/ml
1.6
20.8
1.04
22
170
(3021601) Nitrite [Presence] in Urine by Test strip
293
2534
1.05
0.24
7.0
5.0
estimate
0.0
0.0
0.00
52
441
(4027681)
6
76
0.70
0.24
1.2
1.2
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
5
33
1.35
0.23
1.0
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
34
1.31
0.23
1.2
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
34
1.31
0.23
1.0
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
147
1251
1.06
0.23
4.8
2.9
kg/l
1.0
1.0
1.12
27
235
(3010726) Horse dander IgE Ab [Units/volume] in Serum
73
606
1.08
0.23
1.2
1.2
u/ml
5.1
4.2
0.12
26
205
(40765089) Chromosome analysis panel - Blood by G-banded
15
111
1.21
0.23
1.1
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
81
0.77
0.22
1.3
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
85
0.73
0.22
1.1
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
294
2548
1.04
0.22
5.1
3.4
estimate
0.0
0.0
0.00
54
432
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
17
128
1.19
0.22
1.6
1.2
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
22
170
1.16
0.22
1.5
1.7
u/ml
2.3
9.7
—
7
45
(3002256) Pathology report gross observation
47
383
1.10
0.22
1.2
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
37
1.21
0.22
1.0
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
9
0.00
0.21
0.0
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
9
0.00
0.21
0.0
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
9
0.00
0.21
0.0
2.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
11
0.00
0.21
0.0
1.5
—
44.8
—
0
6
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
132
1233
0.95
0.21
4.3
3.0
—
—
—
0
0
(3015736) pH of Urine
239
2065
1.04
0.21
4.5
3.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
12
0.00
0.20
0.0
1.3
—
—
—
0
0
(4146454)
0
12
0.00
0.20
0.0
3.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.20
0.0
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
12
0.00
0.20
0.0
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
43
1.25
0.20
1.0
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
44
1.22
0.20
1.2
2.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
44
1.22
0.20
1.2
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
44
1.22
0.20
1.2
2.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
89
1.21
0.18
1.2
1.3
—
—
—
0
0
(1002224) Polysomnography panel
7
53
1.18
0.18
1.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
27
216
1.12
0.18
1.4
1.2
—
—
—
0
0
(4034850)
11
81
1.21
0.17
11.1
5.9
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
8
62
1.15
0.16
1.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
8
64
1.12
0.16
1.0
1.0
—
7.6
—
0
6
(3024980) IgG subclass 4 [Mass/volume] in Serum
18
181
0.88
0.15
1.7
1.6
g/l
0.5
0.8
0.87
18
157
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
53
503
0.94
0.15
2.1
2.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
16
162
0.88
0.14
9.6
5.5
u/ml
21.2
23.0
0.04
16
154
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
9
74
1.09
0.14
1.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
77
0.81
0.14
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
102
947
0.96
0.14
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
31
300
0.92
0.14
1.1
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
32
309
0.92
0.14
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
20
160
1.12
0.13
1.5
2.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
18
143
1.13
0.13
5.3
4.2
%
50.8
50.1
0.08
18
143
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
92
1.17
0.13
1.2
1.5
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
32
264
1.08
0.13
5.2
3.9
mg/l
708.1
394.9
0.78
32
259
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
97
0.83
0.13
1.1
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
27
221
1.09
0.13
4.2
3.4
e6/l
456.8
385.5
0.32
22
141
(3014133) Dog dander IgE Ab [Units/volume] in Serum
47
395
1.06
0.12
1.1
1.1
u/ml
13.2
6.6
0.83
28
228
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
20
161
1.11
0.12
1.9
1.7
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
20
161
1.11
0.12
1.1
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
60
509
1.05
0.12
1.6
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
14
110
1.14
0.12
6.9
4.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
54
507
0.95
0.12
1.3
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
85
1.16
0.11
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
85
1.16
0.11
1.1
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
19
186
0.91
0.11
1.9
1.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
33
314
0.93
0.10
1.1
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
367
3231
1.02
0.10
3.4
2.7
mmol/l
2.6
2.6
0.46
345
3026
(3023410) Appearance of Cerebral spinal fluid
21
204
0.92
0.10
7.0
4.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
28
268
0.93
0.10
1.3
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
23
189
1.09
0.10
2.4
1.6
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
108
935
1.03
0.10
1.4
1.3
titre
39.2
368.2
—
6
35
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
135
1235
0.97
0.10
1.6
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
195
1705
1.03
0.10
4.8
3.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
86
1.14
0.09
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
86
1.14
0.09
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
86
1.14
0.09
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
86
1.14
0.09
1.1
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
19
155
1.10
0.09
4.1
4.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
42
1.06
0.09
1.0
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
43
1.04
0.09
1.4
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
25
239
0.93
0.09
1.2
1.3
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
6
48
1.12
0.09
1.3
1.2
—
61.6
—
0
11
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
49
1.09
0.09
1.0
1.5
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
6
49
1.09
0.09
1.0
1.5
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
49
1.09
0.09
1.0
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
384
3461
0.98
0.08
2.6
2.2
mmol/l
5.4
5.3
0.62
347
3175
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
77
665
1.04
0.08
2.2
2.4
u/l
6036.5
6314.9
0.02
19
175
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
54
0.82
0.08
1.0
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
54
0.82
0.08
1.6
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
55
0.81
0.08
2.8
2.8
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
57
0.78
0.08
1.0
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
25
238
0.94
0.08
1.2
1.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
60
1.04
0.08
17.1
4.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
60
1.04
0.08
3.7
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
61
1.02
0.07
1.6
2.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
375
3312
1.02
0.07
3.4
2.8
mmol/l
4.2
4.3
0.40
350
3149
(21494815) CD4 cells/100 lymphocytes in Specimen
26
218
1.07
0.07
5.3
3.5
—
40.8
—
0
5
(3015171) Extractable nuclear Ab [Units/volume] in Serum
15
146
0.91
0.07
1.5
1.2
—
1.1
—
0
10
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
23
192
1.07
0.07
1.1
1.3
mg/l
5.5
4.2
0.21
18
117
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
100
0.89
0.07
1.1
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
37
315
1.05
0.07
1.3
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
17
140
1.08
0.07
5.4
3.7
e9/l
3.6
3.3
0.37
17
140
(3048929) Epstein Barr virus Ab [Presence] in Serum
108
942
1.03
0.07
2.1
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
118
0.91
0.07
1.9
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
118
0.91
0.07
1.9
1.4
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
8
81
0.88
0.07
1.0
1.1
mg/l
462.9
215.1
—
8
76
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
84
0.85
0.06
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
58
534
0.97
0.06
1.2
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
53
457
1.04
0.06
2.6
2.2
nmol/l
10.3
8.5
0.51
40
362
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
17
163
0.93
0.06
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
17
163
0.93
0.06
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
17
163
0.93
0.06
1.6
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
17
163
0.93
0.06
1.6
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
18
172
0.93
0.06
1.6
1.9
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
99
0.90
0.06
3.0
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
135
1185
1.02
0.05
1.8
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
51
441
1.03
0.05
1.9
1.9
mmol/l
2.4
2.4
0.15
40
369
(3017143) Hepatitis C virus Ab [Presence] in Serum
104
911
1.02
0.05
1.4
1.6
—
—
—
0
0
(4062490)
17
142
1.07
0.05
1.7
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
157
1382
1.02
0.05
2.9
3.5
ug/g
119.9
101.7
0.14
131
1094
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
12
116
0.92
0.04
3.8
2.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
29
248
1.04
0.04
2.2
2.0
%
35.4
32.9
0.63
22
189
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
134
0.93
0.04
1.4
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
81
1.10
0.04
1.9
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
42
363
1.03
0.04
1.1
1.1
u/ml
12.6
9.8
0.26
27
225
(3001019) Free T4 and TSH panel - Serum or Plasma
17
143
1.06
0.04
1.2
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
10
97
0.92
0.03
1.2
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
26
224
1.04
0.02
24.1
21.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
16
150
0.95
0.02
20.2
24.2
%
11.6
11.4
0.09
16
150
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
92
1.07
0.01
1.6
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
92
1.07
0.01
1.6
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
11
92
1.07
0.01
1.3
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
18
167
0.96
0.01
1.4
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
28
243
1.03
0.01
5.6
4.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
90
809
0.99
0.01
1.5
1.6
titre
872.7
506.1
0.36
11
132
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
20
184
0.97
0.01
1.5
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
360
3205
1.00
0.00
3.4
2.6
mmol/l
1.4
1.4
1.22
336
3022
(3021879) Hepatitis B virus core Ab [Presence] in Serum
53
478
0.99
0.00
1.3
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
121
0.96
0.00
1.8
1.5
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
16
141
1.01
0.00
1.8
1.3
g/l
1.9
2.2
0.52
16
123
(3027135) IgG subclass 1 [Mass/volume] in Serum
16
141
1.01
0.00
1.8
1.3
g/l
5.6
6.1
0.42
16
122
(3016018) Differential panel - Cerebral spinal fluid
18
162
0.99
0.00
4.7
3.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
41
365
1.00
0.00
1.1
1.2
—
30.9
—
0
8
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
29
256
1.01
0.00
5.5
4.0
e6/l
37.8
8.5
0.37
23
183
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
36
326
0.98
0.00
1.1
1.1
u/ml
1.9
0.3
0.60
19
147
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
28
247
1.01
0.00
1.5
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
15
129
1.04
0.00
1.9
1.8
iu/l
1.8
5.4
—
6
42
(3000330) Specific gravity of Urine by Test strip
20
178
1.00
0.00
2.5
2.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
119
0.97
0.00
2.8
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
35
316
0.99
0.00
1.2
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
29
257
1.01
0.00
5.5
4.0
e6/l
156.7
226.1
0.22
24
190
(3014051) Protein [Presence] in Urine by Test strip
14
121
1.03
0.00
1.8
1.8
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
11
102
0.96
0.00
1.2
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
53
469
1.01
0.00
2.0
2.5
u/l
24.2
28.7
1.11
47
382
(3021387) Prolactin [Units/volume] in Serum or Plasma
51
452
1.01
0.00
1.7
1.6
mu/l
480.4
383.5
0.43
46
417
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
149
1.02
0.00
1.5
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
103
0.95
0.00
1.0
1.1
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
49
0.91
0.00
1.2
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
3.4
—
5.4
—
0
5
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
59
0.91
0.00
1.8
3.0
ug/l
22.4
31.6
—
6
53
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
58
0.92
0.00
16.8
4.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
9
85
0.94
0.00
1.1
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
65
0.96
0.00
1.1
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
2.7
—
0.8
—
0
6
(40760083) Phosphate/Creatinine [Ratio] in Urine
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
9
82
0.98
0.00
1.1
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
9
83
0.97
0.00
1.7
1.8
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
8
72
0.99
0.00
1.5
2.6
—
273.8
—
0
19
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
48
0.93
0.00
3.4
2.3
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
8
73
0.98
0.00
1.1
1.3
umol/l
9.4
9.1
—
8
73
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
66.8
—
0
7
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
52
0.86
0.00
2.4
2.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
9
82
0.98
0.00
1.2
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
54
0.99
0.00
2.3
1.5
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
2.2
—
1492.7
—
0
6
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint P16_RESPI_CARDIOV_DISORD_SPECIFIC_PERINA_PERIOD and mortality.

Females

Parameter HR [95% CI] p-value
P16_RESPI_CARDIOV_DISORD_SPECIFIC_PERINA_PERIOD 1.961 [1.64, 2.34] < 0.001
Birth year 0.997 [0.99, 1.01] 0.451

During the follow-up period (1.1.1998 — 31.12.2019), 199 out of 29349 females with P16_RESPI_CARDIOV_DISORD_SPECIFIC_PERINA_PERIOD died.

Males

Parameter HR [95% CI] p-value
P16_RESPI_CARDIOV_DISORD_SPECIFIC_PERINA_PERIOD 2.368 [2.05, 2.74] < 0.001
Birth year 0.988 [0.98, 1.0] 0.009

During the follow-up period (1.1.1998 — 31.12.2019), 279 out of 38142 males with P16_RESPI_CARDIOV_DISORD_SPECIFIC_PERINA_PERIOD died.

Mortality risk

Mortality risk for people of age

years, who have P16_RESPI_CARDIOV_DISORD_SPECIFIC_PERINA_PERIOD.

N-year risk Females Males
1 0.176% 0.425%
5 1.096% 2.92%
10 2.92% 7.072%
15 5.676% 12.871%
20 10.052% 21.298%

Relationships between endpoints

↥

Index endpoint: P16_RESPI_CARDIOV_DISORD_SPECIFIC_PERINA_PERIOD – Respiratory and cardiovascular disorders specific to the perinatal period

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data